Superworth

GLAUKOS EV/EBIT GKOS

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2017.

Today, Oct 23, 2026
n/m
an operating loss
Last meaningful
355×
May 2018
Peer median
17.6×

GLAUKOS has no meaningful EV/EBIT today: it made an operating loss of $193.4M over the last twelve months.

It was last meaningful in May 2018, at 355×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2018355×267×355×
2017260×256×410×

Against its peers

Companies in Medical - Instruments & Supplies nearest GLAUKOS' size, closest first, today.

CompanyEV/EBIT
GKOSGLAUKOSn/m
PODDInsulet20.4×
GMEDGlobus Medical16.3×
ALGNAlign Technology16.2×
COOCooper Companies17.2×
PENPenumbra65.8×
SOLVSolventum8.4×
MSAMSA Safety18.0×
MMSIMerit Medical Systems28.6×
HAEHaemonetics26.8×
VNTVontier10.9×
Peer median17.6×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on GLAUKOS

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.